{
    "zip": "CB2 0AA",
    "sector": "Healthcare",
    "longBusinessSummary": "AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide. Its marketed products include Arimidex, Casodex/Cosudex, Calquence, Faslodex, Imfinzi, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand1/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor, Plendil, Seloken/Toprol-XL, Tenormin, and Zestril for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR, Komboglyze, Onglyza, Qtern, Symlin, Xigduo, and Xigduo XR for metabolic diseases. The company's marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Eklira Genuair/Tudorza Pressair, Fasenra, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, Symbicort Turbuhaler, and Tudorza Pressair for respiratory diseases; Fluenz FluMist/Tetra Quadrivalen and Synagis3 for infection diseases; Movantik/Moventig, Seroquel IR, Seroquel XR, and Vimovo for neuroscience diseases; and Losec/Prilosec and Nexium for gastrointestinal diseases. The company serves primary care and specialty care physicians through distributors and local representative offices. AstraZeneca PLC has a collaboration and license option agreement with Transgene SA, Ironwood Pharmaceuticals, Inc., and MiNA Therapeutics; and master collaboration agreement Biocartis. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom.",
    "city": "Cambridge",
    "phone": "44 20 3749 5000",
    "country": "United Kingdom",
    "companyOfficers": [],
    "website": "http://www.astrazeneca.com",
    "maxAge": 1,
    "address1": "1 Francis Crick Avenue",
    "industry": "Drug Manufacturers\u2014General",
    "address2": "Cambridge Biomedical Campus",
    "previousClose": 45.52,
    "regularMarketOpen": 47.28,
    "twoHundredDayAverage": 47.13103,
    "trailingAnnualDividendYield": 0.061511423,
    "payoutRatio": 2.7184,
    "volume24Hr": null,
    "regularMarketDayHigh": 48.685,
    "navPrice": null,
    "averageDailyVolume10Day": 4697071,
    "totalAssets": null,
    "regularMarketPreviousClose": 45.52,
    "fiftyDayAverage": 48.894413,
    "trailingAnnualDividendRate": 2.8,
    "open": 47.28,
    "averageVolume10days": 4697071,
    "expireDate": null,
    "yield": null,
    "algorithm": null,
    "dividendRate": 1.4,
    "exDividendDate": 1582761600,
    "beta": 0.268533,
    "circulatingSupply": null,
    "startDate": null,
    "regularMarketDayLow": 46.74,
    "priceHint": 2,
    "currency": "USD",
    "trailingPE": 94.73684,
    "regularMarketVolume": 3247172,
    "lastMarket": null,
    "maxSupply": null,
    "openInterest": null,
    "marketCap": 128262692864,
    "volumeAllCurrencies": null,
    "strikePrice": null,
    "averageVolume": 2965298,
    "priceToSalesTrailing12Months": 5.260117,
    "dayLow": 46.74,
    "ask": 48.69,
    "ytdReturn": null,
    "askSize": 1200,
    "volume": 3247172,
    "fiftyTwoWeekHigh": 51.55,
    "forwardPE": 19.596773,
    "fromCurrency": null,
    "fiveYearAvgDividendYield": 4.05,
    "fiftyTwoWeekLow": 36.83,
    "bid": 48.68,
    "tradeable": true,
    "dividendYield": 0.0308,
    "bidSize": 1200,
    "dayHigh": 48.685,
    "exchange": "NYQ",
    "shortName": "Astrazeneca PLC",
    "longName": "AstraZeneca PLC",
    "exchangeTimezoneName": "America/New_York",
    "exchangeTimezoneShortName": "EST",
    "isEsgPopulated": false,
    "gmtOffSetMilliseconds": "-18000000",
    "quoteType": "EQUITY",
    "symbol": "AZN",
    "messageBoardId": "finmb_336774",
    "market": "us_market",
    "annualHoldingsTurnover": null,
    "enterpriseToRevenue": 5.541,
    "beta3Year": null,
    "profitMargins": 0.05475,
    "enterpriseToEbitda": 22.976,
    "52WeekChange": 0.083035946,
    "morningStarRiskRating": null,
    "forwardEps": 2.48,
    "revenueQuarterlyGrowth": null,
    "sharesOutstanding": 2624369920,
    "fundInceptionDate": null,
    "annualReportExpenseRatio": null,
    "bookValue": 5.0025,
    "sharesShort": 6815803,
    "sharesPercentSharesOut": 0.003,
    "fundFamily": null,
    "lastFiscalYearEnd": 1577750400,
    "heldPercentInstitutions": 0.18372,
    "netIncomeToCommon": 1335000064,
    "trailingEps": 0.513,
    "lastDividendValue": null,
    "SandP52WeekChange": 0.08368194,
    "priceToBook": 9.715142,
    "heldPercentInsiders": 5e-05,
    "nextFiscalYearEnd": 1640908800,
    "mostRecentQuarter": 1577750400,
    "shortRatio": 2.78,
    "sharesShortPreviousMonthDate": 1579046400,
    "floatShares": 2615681920,
    "enterpriseValue": 135122477056,
    "threeYearAverageReturn": null,
    "lastSplitDate": 1437955200,
    "lastSplitFactor": "2:1",
    "legalType": null,
    "morningStarOverallRating": null,
    "earningsQuarterlyGrowth": -0.697,
    "dateShortInterest": 1581638400,
    "pegRatio": 1.25,
    "lastCapGain": null,
    "shortPercentOfFloat": null,
    "sharesShortPriorMonth": 4027264,
    "category": null,
    "fiveYearAverageReturn": null,
    "regularMarketPrice": 47.28,
    "logo_url": "https://logo.clearbit.com/astrazeneca.com"
}